|
Dr. Schoenhard serves as PTI's Chief Scientific Officer, a promotion from his previous position with the Company as Vice President of Preclinical Development. Prior to joining PTI, Dr. Schoenhard was Sr. Director of Pharmacokinetics, Drug Metabolism and Pharmacology at Genentech, Inc. From 1974 to 1998, Dr. Schoenhard also held various management positions at Searle, a pharmaceutical company of Monsanto Corp., including Executive Director of Pharmacokinetics, Drug Metabolism and Radiochemistry. He is also Adjunct Professor of Pharmacology, School of Medicine, University of Pennsylvania. Dr. Schoenhard received his BS from Michigan State University and his MS and PhD from Oregon State University. | 